Inhibitors of the PLK1 polo-box domain: drug design strategies and therapeutic opportunities in cancer
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Drug Discovery"
DOI: 10.1080/17460441.2023.2159942
Abstract: ABSTRACT Introduction Polo Like Kinase 1 (PLK1) is a key regulator of mitosis and its overexpression is frequently observed in a wide variety of human cancers, while often being associated with poor survival rates. Therefore,… read more here.
Keywords: pbd; polo box; inhibitors plk1; plk1 polo ... See more keywords